Literature DB >> 12404599

Neurotrophins: possible role in affective disorders.

M Sandler1.   

Abstract

Various monoamine hypotheses of affective disorders have been unable to provide a complete explanation for the observed clinical findings. Recently Duman et al. (1997) have produced a molecular and cellular theory of depression which seems to be a worthy successor to these hypotheses. Whereas the earlier theories were unable to explain the time lag between antidepressant drug administration and lightening of affect, Duman's group pinpoints intracellular mechanisms, in the right time frame, which decrease or increase the generation of neurotrophic factors necessary for the survival of certain neurons, particularly in the hippocampus. This new concept may lead to novel therapeutic approaches. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Year:  2001        PMID: 12404599     DOI: 10.1002/hup.184

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  4 in total

1.  Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

Authors:  Brian A Hoshaw; Tiffany I Hill; James J Crowley; Jessica E Malberg; Xavier Khawaja; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Journal:  Eur J Pharmacol       Date:  2008-07-17       Impact factor: 4.432

2.  Merton Sandler (March 1926-August 2014).

Authors:  Irwin Kopin; Rita Kopin
Journal:  J Neural Transm (Vienna)       Date:  2015-02       Impact factor: 3.575

Review 3.  Serotonin-kynurenine hypothesis of depression: historical overview and recent developments.

Authors:  Gregory Oxenkrug
Journal:  Curr Drug Targets       Date:  2013-05-01       Impact factor: 3.465

4.  N-acetylserotonin and aging-associated cognitive impairment and depression.

Authors:  Gregory Oxenkrug; Rebbie Ratner
Journal:  Aging Dis       Date:  2012-06-19       Impact factor: 6.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.